null - FindTrial

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

EU CTR

Registry ID

EUCTR2012-002412-95-FI

Enrollment

200

Registered

2012-06-19

Start date

2012-07-18

Completion date

Unknown

Last updated

2025-01-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Keskivaikeaa/vaikeaa atooppista ihottumaa sairastavat 1-3-vuotiaat lapset MedDRA version: 14.1 Level: LLT Classification code 10003641 Term: Atopic eczema System Organ Class: 10040785 - Skin and subcutaneous tissue disorders

Interventions

Trade Name: Protopic -voide Product Name: Protopic Pharmaceutical Form: Ointment INN or Proposed INN: Takrolimuusi CAS Number: 104987-11-3 Concentration unit: % (W/W) percent weight/weight Concentrati

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Are the trial subjects under 18? yes Number of subjects for this age range: 200 F.1.2 Adults (18-64 years) no F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) no F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Main Objective: Atooppisen ihottuman tehokkaan hoidon vaikutus allergiseen nuhaan ja/tai astmaan 1-3-vuotiailla lapsilla ;Secondary Objective: ;Primary end point(s):	—

Countries

Finland

Contacts

Public ContactAnita Remitz

Iho-ja allergiasairaala

anita.remitz@hus.fi3589471 86355

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 9, 2026